CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | 88.45%6.44B | 155.27%6.56B | 169.28%5.56B | 54.30%3.5B | 39.31%3.42B | 110.80%2.57B | 257.15%2.06B | 196.63%2.27B | 36.75%2.45B | -24.17%1.22B |
Transactional financial assets | 109.10%1.23B | 141.76%929.97M | -28.49%532.36M | 60.43%684.61M | 244.63%587.6M | -55.01%384.67M | 107.23%744.44M | 132.79%426.74M | -9.31%170.5M | --854.92M |
Notes receivable and accounts receivable | 311.85%456.37M | 27.37%136.25M | -62.26%65.66M | 233.18%207.91M | 502.64%110.81M | 140.43%106.98M | 540.99%173.98M | 819.14%62.4M | 127.98%18.39M | 397.52%44.49M |
-Accounts receivable | 311.85%456.37M | 27.37%136.25M | -62.26%65.66M | 233.18%207.91M | 502.64%110.81M | 140.43%106.98M | 540.99%173.98M | 819.14%62.4M | 127.98%18.39M | 397.52%44.49M |
Other receivables (including interest and dividends) | 37.73%19.02M | 573.88%56.56M | -12.29%13.81M | -58.81%8.37M | -50.90%13.81M | -72.55%8.39M | -7.16%15.74M | 740.06%20.32M | -90.62%28.12M | -42.51%30.57M |
-Accrued interest receivable | ---- | ---- | ---- | ---- | -40.16%1.89M | -5.00%1.89M | 0.00%1.99M | --1.99M | --3.16M | --1.99M |
-Other receivable | ---- | ---- | ---- | -54.34%8.37M | ---- | -77.25%6.5M | ---- | 657.79%18.33M | ---- | -46.25%28.58M |
Advance payment | 1.80%24.13M | 61.58%9.09M | 706.81%39.16M | 249.42%21.13M | 184.27%23.7M | -11.82%5.62M | -72.92%4.85M | 39.45%6.05M | -7.08%8.34M | -0.30%6.38M |
Inventories | -32.32%297.76K | -65.40%168.07K | -59.10%217.85K | -55.09%252.26K | -25.65%439.94K | -55.62%485.81K | -9.86%532.67K | -10.16%561.69K | -8.44%591.69K | 4.95%1.09M |
Other current assets | 100.85%55.52M | 93.72%54.97M | -3.32%33.49M | -34.84%41.46M | -42.33%27.64M | -52.25%28.37M | -9.27%34.64M | 337.11%63.63M | 249.81%47.93M | 233.41%59.43M |
Total current assets | 103.34%9.13B | 146.50%8.62B | 103.19%6.67B | 58.49%4.84B | 23.20%4.49B | 46.02%3.5B | 141.56%3.28B | 212.31%3.05B | 57.59%3.65B | 41.29%2.39B |
Non Current assets | ||||||||||
Other equity investment | -24.45%95.41M | 493.47%95.41M | --16.47M | --16.47M | --126.29M | --16.08M | ---- | ---- | ---- | --0 |
Investment real estate | -5.79%1.94M | -5.70%1.97M | -5.62%2M | -5.55%2.03M | -5.47%2.06M | -5.40%2.09M | -4.98%2.12M | --2.15M | --2.18M | --2.21M |
Long-term equity investment | ---- | --126.68M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Fixed assets | ---- | ---- | ---- | -4.76%371.19M | ---- | -3.78%373.56M | ---- | 20.34%389.75M | ---- | 18.39%388.24M |
Intangible assets | 58.91%92.81M | 12.83%68.12M | 40.34%66.57M | 45.79%67.57M | 38.62%58.4M | 39.05%60.38M | 33.56%47.43M | 1,521.39%46.35M | 1,258.15%42.13M | 1,223.87%43.42M |
Goodwill | 23.49%1.59B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | 0.00%1.29B | --1.29B | --1.29B | --1.29B |
Long deferred expense | 21.31%17.45M | 79.88%18.17M | 68.84%17.24M | 62.69%12.17M | 157.84%14.39M | 100.14%10.1M | 168.17%10.21M | 950.08%7.48M | 359.36%5.58M | 200.68%5.05M |
Deferred tax assets | 18.75%145.65M | 35.40%172.94M | 12.52%146.86M | 12.47%130.85M | 10.63%122.65M | 16.92%127.72M | 1,334.63%130.52M | 832.86%116.34M | 753.13%110.86M | 627.47%109.24M |
Usufruct assets | 28.94%52.57M | 22.17%54.49M | 10.77%46.34M | 46.28%48.89M | 15.82%40.77M | 22.11%44.6M | 69.29%41.83M | 321.49%33.42M | 1,267.59%35.2M | 1,321.09%36.53M |
Other non current assets | -11.15%15.55M | 289.53%51.65M | 5,094.19%140.55M | 3,635.22%127.12M | 655.32%17.5M | 949.89%13.26M | 214.42%2.71M | -99.77%3.4M | 322.92%2.32M | 422.03%1.26M |
Total non current assets | 17.22%2.39B | 16.56%2.25B | 9.69%2.09B | 9.41%2.06B | 8.54%2.04B | 3.30%1.93B | 8.92%1.91B | 2.00%1.89B | 444.06%1.88B | 433.91%1.87B |
Total assets | 76.46%11.52B | 100.22%10.87B | 68.84%8.77B | 39.74%6.9B | 18.22%6.53B | 27.27%5.43B | 66.89%5.19B | 74.73%4.94B | 107.75%5.52B | 108.60%4.27B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Short term loan | 182.96%550.76M | 109.36%402.89M | 86.07%451.95M | 51.43%335.83M | -4.04%194.64M | 28.70%192.44M | --242.89M | -11.39%221.77M | 35.04%202.83M | 100.08%149.53M |
Notes payable and accounts payable | 126.05%162.04M | 87.61%113.46M | 492.32%326.72M | 37.28%109.14M | -78.06%71.68M | 30.11%60.48M | 31.71%55.16M | 249.37%79.5M | 1,020.32%326.77M | 23.53%46.48M |
-Accounts payable | 126.05%162.04M | 87.61%113.46M | 492.32%326.72M | 37.28%109.14M | -78.06%71.68M | 30.11%60.48M | 31.71%55.16M | 249.37%79.5M | 1,020.32%326.77M | 23.53%46.48M |
Contract liabilities | 118.92%72.11M | 99.26%77.4M | 6.57%42.99M | 41.40%47.05M | -0.53%32.94M | 0.99%38.85M | 16.10%40.34M | 5.09%33.27M | -30.53%33.11M | -6.29%38.47M |
Advance receipts | 0.00%142.74K | -0.02%97.24K | -68.07%182.73K | 3.09%57.27K | 2.77%142.74K | 10.63%97.26K | 434.37%572.21K | --55.56K | --138.89K | --87.91K |
Salaries payable | 184.65%219.83M | 146.72%259.95M | 102.22%77.18M | 29.79%88.39M | 0.41%77.23M | 32.99%105.36M | -58.63%38.17M | -52.26%68.1M | -54.55%76.91M | -6.70%79.23M |
Taxs payable | -16.57%14.54M | 320.11%22.96M | 8.56%5.12M | 51.82%5.39M | 75.68%17.42M | 163.57%5.46M | -0.77%4.72M | -21.50%3.55M | -83.24%9.92M | -74.55%2.07M |
Other payable (including interest and dividends) | 14.70%54.49M | 2.42%48.82M | 105.99%99.2M | -1.49%48.48M | 0.32%47.5M | -4.42%47.66M | 120.20%48.16M | 246.24%49.22M | 239.06%47.35M | 258.09%49.87M |
-Other payable | ---- | ---- | ---- | -1.49%48.48M | ---- | -4.42%47.66M | ---- | 246.24%49.22M | ---- | 258.09%49.87M |
Non current liabilities due within one year | 52.19%23.11M | 28.65%18.73M | 66.14%19.49M | 60.62%16.51M | 62.44%15.19M | 54.04%14.56M | 56.96%11.73M | 368.45%10.28M | 511.23%9.35M | 550.22%9.45M |
Other current liabilities | 11.01%9.27M | 5.22%9.2M | 1.33%8.56M | 9.78%8.85M | 5.74%8.35M | 5.69%8.74M | 4.67%8.45M | 1,401.05%8.06M | 487.11%7.89M | 1,277.69%8.27M |
Total current liabilities | 114.28%8.47B | 172.15%7.85B | 124.51%6.34B | 74.72%4.38B | 28.18%3.95B | 49.31%2.88B | 271.71%2.82B | 434.33%2.5B | 552.97%3.08B | 635.81%1.93B |
Current liabilities | ||||||||||
Long term salaries pay | --1.14M | --1.24M | --1.3M | --1.39M | ---- | ---- | ---- | ---- | ---- | ---- |
Estimate liabilities | ---- | ---- | --751.55K | --751.55K | ---- | ---- | ---- | ---- | ---- | ---- |
Deferred tax liabilities | -2.04%5M | -6.10%4.87M | -5.85%4.95M | 1.03%5.03M | -6.03%5.11M | -7.26%5.19M | -11.36%5.26M | --4.98M | --5.43M | --5.59M |
Long term deferred income | -4.26%2.24M | -4.21%2.27M | -4.17%2.29M | -4.12%2.32M | -4.08%2.34M | -4.04%2.37M | -4.00%2.39M | -3.96%2.42M | -3.92%2.44M | -3.88%2.47M |
Lease liabilities | 22.90%31.38M | 18.75%34.75M | -7.25%26.82M | 40.59%31.56M | 3.82%25.53M | 14.10%29.27M | 85.39%28.91M | 311.40%22.45M | 2,819.06%24.59M | 2,636.22%25.65M |
Other non current liabilities | 20.77%797.27M | 15.25%757.68M | -2.28%590.79M | 2.51%651.71M | 0.36%660.13M | 5.86%657.45M | -7.66%604.58M | -4.61%635.75M | 4.21%657.78M | 24.82%621.07M |
Total non current liabilities | 20.76%837.03M | 15.35%800.81M | -2.22%626.9M | 4.08%692.77M | 0.41%693.11M | 6.03%694.27M | -5.54%641.14M | -1.31%665.6M | 8.77%690.25M | 30.68%654.78M |
Total liabilities | 100.32%9.31B | 141.72%8.65B | 101.05%6.96B | 59.89%5.07B | 23.10%4.65B | 38.35%3.58B | 140.83%3.46B | 177.33%3.17B | 240.97%3.77B | 238.68%2.59B |
Shareholders equity | ||||||||||
Paid-in capital | 46.29%598.26M | 0.89%412.56M | 0.15%409.5M | 0.11%408.98M | 0.48%408.96M | 0.48%408.94M | 0.47%408.88M | 0.40%408.52M | 0.49%406.99M | 0.49%406.97M |
Capital reserve funds | -19.33%362.28M | 60.55%700.83M | 16.75%496.95M | 14.26%461.55M | 28.89%449.12M | 28.86%436.52M | 26.95%425.63M | 20.98%403.94M | 32.69%348.44M | 30.25%338.75M |
Surplus reserve funds | 2.52%114.67M | 2.52%114.67M | 5.44%111.85M | 5.44%111.85M | 5.43%111.85M | 5.44%111.85M | 38.05%106.09M | 38.05%106.09M | 38.05%106.09M | 38.05%106.09M |
Retained profit | 21.86%1.14B | 11.07%1.02B | -0.32%806.18M | -0.06%867.18M | 2.89%932.92M | 7.87%916.13M | -5.32%808.74M | 0.36%867.66M | 12.37%906.69M | 57.23%849.29M |
Other composite income | ---- | ---- | ---- | ---- | ---389.99K | ---389.99K | ---- | ---- | ---- | ---- |
Ordinary risk reserve funds | --19.3M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 17.29%2.23B | 19.89%2.25B | 4.30%1.82B | 3.55%1.85B | 7.59%1.9B | 10.11%1.87B | 4.55%1.75B | 6.18%1.79B | 13.98%1.77B | 32.68%1.7B |
Minority interests | 10.63%-17.76M | -0.05%-19.88M | -0.05%-19.88M | -0.05%-19.88M | -0.05%-19.87M | -0.05%-19.87M | ---19.87M | ---19.87M | ---19.86M | ---19.86M |
Total shareholder equity | 17.58%2.21B | 20.10%2.23B | 4.34%1.8B | 3.59%1.83B | 7.68%1.88B | 10.23%1.85B | 3.36%1.73B | 5.00%1.77B | 12.70%1.75B | 31.13%1.68B |
Total liabilityies and equity | 76.46%11.52B | 100.22%10.87B | 68.84%8.77B | 39.74%6.9B | 18.22%6.53B | 27.27%5.43B | 66.89%5.19B | 74.73%4.94B | 107.75%5.52B | 108.60%4.27B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.